Eliott Harfouche, Managing Partner of Nodes Advisors, and Head of Corporate Finance will present at the Festival Biologics
PITFALLS TO AVOID WHEN BUILDING AND FUNDRAISING FOR COMPUTATIONAL BIOTECH STARTUPS:
• The early signals of progress for traditional tech companies are well known — product, revenue, customers — biotech companies operate under a very different metrics, timelines, and milestones.
• Building & and fundraising a company that bridges computer science and biology therefore requires understanding the inflection points that signal value creation — for investors
• In this presentation we’ll go over the pitfalls to avoid when building and fundraising for therapeutics companies at the intersection of software and biology